Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report
30 Avril 2020 - 7:59AM
Amsterdam, The Netherlands, and
Holzgerlingen, Germany, April 30, 2020, 08:00 am CET -
Curetis N.V. in liquidatie (the "Company") today
announced that the publication of its audited 2019 full year
financial results and 2019 Annual Report originally scheduled for
April 30, 2020 will be delayed to a later date expected in May
2020. The delay is caused by the impact of the COVID-19 pandemic on
the Company’s finance department’s operations, its external
advisors, including a purely remote and off-site auditing effort
required as part of the liquidation of the Company.
The publication of the audited 2019 full year
financial results and 2019 Annual Report will hence follow and
happen after the last day of trading of the Company’s shares on
Euronext that is scheduled for May 4, 2020 and the Distribution in
Advance payable on May 7 2020 to the Company’s shareholders holding
shares in the Company on the Distribution Record Date on 6 May 2020
of 1,622,568 shares of OpGen Inc., a Delaware corporation, common
stock currently held by Curetis N.V.
For more information about the Distribution in
Advance, the transaction with OpGen and the delisting of the
Company’s shares from Euronext Amsterdam and Euronext Brussels, the
Company kindly refers to the Shareholder Circular and the
extraordinary general meeting, held on March 10, 2020 and the press
release issued by the Company on April 20, 2020 available on the
Company’s website at: www.curetis-nv.com.
###
Legal Disclaimer This document
constitutes neither an offer to buy nor an offer to subscribe for
securities and neither this document nor any part of it should form
the basis of any investment decision in Curetis.
The information contained in this press release has been
carefully prepared. However, Curetis bears and assumes no liability
of whatever kind for the correctness and completeness of the
information provided herein. Curetis does not assume an obligation
of whatever kind to update or correct information contained in this
press release whether as a result of new information, future events
or for other reasons.
This press release includes statements that are, or may be
deemed to be, “forward-looking statements.” These forward-looking
statements can be identified by the use of forward-looking
terminology, including the terms “believes,” “estimates,”
“anticipates,” “expects,” “intends,” “targets,” “may,” “will,” or
“should” and include statements Curetis makes concerning the
intended results of its strategy. By their nature, forward-looking
statements involve risks and uncertainties and readers are
cautioned that any such forward-looking statements are not
guarantees of future performance. Curetis’ actual results may
differ materially from those predicted by the forward-looking
statements. Curetis undertakes no obligation to publicly update or
revise forward-looking statements, except as may be required by
law.
Contact detailsCuretis N.V. in liquidatie
Max-Eyth-Str. 42 71088 Holzgerlingen, Germany Tel. +49 7031
49195-10 www.curetis-nv.com
- 20200430_Curetis_NV_PR_Delay_AR2019_APPROVED
Direxion Daily Healthcar... (AMEX:CURE)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Direxion Daily Healthcar... (AMEX:CURE)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024